Key result
Sympathetic denervation of pulmonary arteries was investigated for reducing pulmonary hypertension and managing atrial fibrillation, but no results are reported in the abstract.
Why the study?
It was unclear whether sympathetic denervation of the trunk and orifices of pulmonary arteries could reduce pulmonary hypertension and assist in managing atrial fibrillation in patients with mitral valve dysfunction complicated by atrial fibrillation and high pulmonary pressure.
Key points are not available for this paper at this time.
Population
Patients with mitral valve dysfunction complicated by atrial fibrillation and high pulmonary pressure
Comparison
Sympathetic denervation of the trunk and orifices of pulmonary arteries
No results reported; leaves open whether pulmonary artery sympathetic denervation benefits pulmonary hypertension or AF.
The aim of the study was to evaluate whether sympathetic denervation of the trunk and orifices of pulmonary arteries could reduce pulmonary hypertension and help in managing atrial fibrillation. In addition, we aimed to identify the main predictors of recurrent rhythm disturbances in patients with mitral valve dysfunction complicated by atrial fibrillation and high pulmonary pressure.
No takes yet. Share an insight, caveat, or question.
Трофимов et al. (2019) studied this question. Sympathetic denervation of pulmonary arteries was investigated for reducing pulmonary hypertension and managing atrial fibrillation, but no results are reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: